Cidara develops drugs to prevent influenza in individuals at higher risk of complications. Merck has been seeking deals to bolster future revenue as its patent for Keytruda ends in 2028, MarketWatch ...

Dow's 17% plunge and 50% dividend cut reflect deep cyclical challenges, weak margins, and heavy debt, making the stock risky at current levels. Management is taking tough actions—cost cuts, plant ...

U.S. stocks hit their highest levels of the session in recent trading, with the Dow, S&P 500 and Nasdaq composite all setting fresh intraday records, according to Dow Jones Market Data. For the S&P ...

A little-known law signed by Gov. Newsom last fall extends the terms of California’s elected sheriffs and district attorneys by two years, shifting those elections in most counties to align with ...

Industrial chemical companies like LyondellBasell and Dow are weathering an industrywide slowdown. UPS has been hit with sluggish shipping and delivery volumes. All three have dividend payouts that ...

Berkshire Hathaway is hovering around an all-time high despite broader market turbulence. Financials is the heaviest-weighted sector in the Dow. Berkshire has a decent case for being included in the ...